Cargando…
Novel Antidiabetic Agents and Their Effects on Lipid Profile: A Single Shot for Several Cardiovascular Targets
Type-2 diabetes mellitus (DM) represents one of the most important risk factors for cardiovascular diseases (CVD). Hyperglycemia and glycemic variability are not the only determinant of the increased cardiovascular (CV) risk in diabetic patients, as a frequent metabolic disorder associated with DM i...
Autores principales: | Piccirillo, Francesco, Mastroberardino, Sara, Nusca, Annunziata, Frau, Lorenzo, Guarino, Lorenzo, Napoli, Nicola, Ussia, Gian Paolo, Grigioni, Francesco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10299555/ https://www.ncbi.nlm.nih.gov/pubmed/37373310 http://dx.doi.org/10.3390/ijms241210164 |
Ejemplares similares
-
Glycaemic Control in Patients Undergoing Percutaneous Coronary Intervention: What Is the Role for the Novel Antidiabetic Agents? A Comprehensive Review of Basic Science and Clinical Data
por: Nusca, Annunziata, et al.
Publicado: (2022) -
Effects of Finerenone on Cardiovascular and Chronic Kidney Diseases: A New Weapon against Cardiorenal Morbidity and Mortality—A Comprehensive Review
por: Piccirillo, Francesco, et al.
Publicado: (2023) -
Ranolazine Improves Glycemic Variability and Endothelial Function in Patients with Diabetes and Chronic Coronary Syndromes: Results from an Experimental Study
por: Nusca, Annunziata, et al.
Publicado: (2021) -
The Pivotal Role of Invasive Functional Assessment in Patients With Myocardial Infarction With Non-Obstructive Coronary Arteries (MINOCA)
por: Mangiacapra, Fabio, et al.
Publicado: (2021) -
Percutaneous Repair of Atrial Functional Tricuspid Regurgitation in Cardiac Amyloidosis: Combining Linear With Lateral Thinking
por: Nusca, Annunziata, et al.
Publicado: (2022)